Oncomatryx Biopharma
$11.7M
Funding date
Valuation / Funding
No funding history available
Funding data has not been imported for this company yet
Current Valuation Metrics
Oncomatryx Biopharma is currently valued at N/A as of July 14, 2025. The company has raised a total of $78.5M in funding.
Investment Perspective
Oncomatryx Biopharma's valuation reflects investor confidence in the company's market position, growth potential, and ability to execute on its business model. Private market valuations are determined by primary funding rounds and secondary market transactions, which take into account financial performance, market conditions, and growth prospects.
What is Oncomatryx Biopharma Worth in 2025?
As of 2025, Oncomatryx Biopharma is valued at N/A, based on the company's PE Growth/Expansion funding round in July 14, 2025. This valuation positions Oncomatryx Biopharma as one of the leading private companies in the sector.
Oncomatryx Biopharma Valuation History
Oncomatryx Biopharma's funding history demonstrates steady growth and investor confidence.
How Oncomatryx Biopharma Valuation is Determined
Private company valuations like Oncomatryx Biopharma's are determined through primary funding rounds led by venture capital firms, private equity investors, and strategic partners. The valuation reflects factors including:
- Revenue growth and financial performance
- Market opportunity and total addressable market (TAM)
- Competitive positioning and market share
- Management team strength and execution capability
- Technology and intellectual property
- Industry trends and investor sentiment
Oncomatryx Biopharma Valuation FAQs
Is Oncomatryx Biopharma profitable?
Oncomatryx Biopharma has not publicly disclosed its profitability status. Many high-growth private companies prioritize market expansion and user growth over profitability in their early stages.
How does Oncomatryx Biopharma's valuation compare to competitors?
Oncomatryx Biopharma is valued at N/A, positioning it as a major player in the space. Secondary market pricing and private market transactions provide ongoing validation of this valuation.
When will Oncomatryx Biopharma IPO?
Oncomatryx Biopharma has not announced plans for an initial public offering. Until an IPO, investors can access Oncomatryx Biopharma shares through secondary market platforms.